160 related articles for article (PubMed ID: 27484319)
1. Promoting Global Health - Prevention and Treatment of Substance Abuse and HIV in Asia.
Li MD; Hser YI; Chen Z; Chang L
J Neuroimmune Pharmacol; 2016 Sep; 11(3):379-82. PubMed ID: 27484319
[TBL] [Abstract][Full Text] [Related]
2. Editors' Commentary for Special Issue: The 2017 CALDAR Summer Institute and International Conference Promoting Global Health-Precision Research in Substance Abuse, HIV, and Care.
Chang L; Li MD; Hser YI
J Neuroimmune Pharmacol; 2018 Dec; 13(4):427-429. PubMed ID: 30382511
[TBL] [Abstract][Full Text] [Related]
3. Unraveling neuroHIV in the Presence of Substance Use Disorders.
Lin Y; He JJ; Sorensen R; Chang L
J Neuroimmune Pharmacol; 2020 Dec; 15(4):578-583. PubMed ID: 33215327
[TBL] [Abstract][Full Text] [Related]
4. The 2017 CALDAR Summer Institute and International Conference Promoting Global Health-Precision Research in Substance Abuse, HIV, and Care.
Hser YI; Li MD; Grella C; Brecht L; Chen Z; Chang SL; Chang L; Normand J; Tai B
J Neuroimmune Pharmacol; 2017 Jun; 12(Suppl 2):79-80. PubMed ID: 28497234
[TBL] [Abstract][Full Text] [Related]
5. Drug Abuse, HIV, and HCV in Asian Countries.
Hser YI; Liang D; Lan YC; Vicknasingam BK; Chakrabarti A
J Neuroimmune Pharmacol; 2016 Sep; 11(3):383-93. PubMed ID: 27000123
[TBL] [Abstract][Full Text] [Related]
6. Preface. Emerging targets and therapeutics in the treatment of psychostimulant abuse.
Dwoskin LP
Adv Pharmacol; 2014; 69():xi-xiii. PubMed ID: 24484989
[No Abstract] [Full Text] [Related]
7. NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.
Tross S; Campbell AN; Calsyn DA; Metsch LR; Sorensen JL; Shoptaw S; Haynes L; Woody GE; Malow RM; Brown LS; Feaster DJ; Booth RE; Mandler RN; Masson C; Holmes BW; Colfax G; Brooks AJ; Hien DA; Schackman BR; Korthuis PT; Miele GM;
Am J Drug Alcohol Abuse; 2011 Sep; 37(5):283-93. PubMed ID: 21854270
[TBL] [Abstract][Full Text] [Related]
8. Abstracts from the Second Meeting of the Biennial Conference Series to Promote Global Health, April 22–24, 2015, Hangzhou, China.
J Neuroimmune Pharmacol; 2015 Apr; 10 Suppl 1():1-55. PubMed ID: 25697945
[No Abstract] [Full Text] [Related]
9. A review of medical and substance use co-morbidities in Central Asian prisons: implications for HIV prevention and treatment.
Vagenas P; Azbel L; Polonsky M; Kerimi N; Mamyrov M; Dvoryak S; Altice FL
Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S25-31. PubMed ID: 23932844
[TBL] [Abstract][Full Text] [Related]
10. Substance use disorders and HIV/AIDS prevention and treatment intervention: research and practice considerations.
Campbell AN; Tross S; Calsyn DA
Soc Work Public Health; 2013; 28(3-4):333-48. PubMed ID: 23731423
[TBL] [Abstract][Full Text] [Related]
11. Use of mental health and substance abuse treatment services among adults with HIV in the United States.
Burnam MA; Bing EG; Morton SC; Sherbourne C; Fleishman JA; London AS; Vitiello B; Stein M; Bozzette SA; Shapiro MF
Arch Gen Psychiatry; 2001 Aug; 58(8):729-36. PubMed ID: 11483138
[TBL] [Abstract][Full Text] [Related]
12. HIV, AIDS, and other health risks: findings from a multisite study--an introduction.
Himmelgreen DA; Singer M
Am J Drug Alcohol Abuse; 1998 May; 24(2):187-97. PubMed ID: 9643461
[TBL] [Abstract][Full Text] [Related]
13. Drug injecting and HIV infection among the population of drug abusers in Asia.
Poshyachinda V
Bull Narc; 1993; 45(1):77-90. PubMed ID: 8305908
[TBL] [Abstract][Full Text] [Related]
14. The Relationship Between Client Characteristics and Wraparound Services in Substance Use Disorder Treatment Centers.
Paino M; Aletraris L; Roman P
J Stud Alcohol Drugs; 2016 Jan; 77(1):160-9. PubMed ID: 26751366
[TBL] [Abstract][Full Text] [Related]
15. Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse.
Khalsa JH; Treisman G; McCance-Katz E; Tedaldi E
Subst Abus; 2008; 29(3):5-16. PubMed ID: 19042203
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of obesity among U.S. population with substance dependence.
Hu L; Oden N; Tai B; VanVeldhuisen P
Drug Alcohol Depend; 2020 Dec; 217():108293. PubMed ID: 32980787
[TBL] [Abstract][Full Text] [Related]
17. Substance abuse and HIV infection.
Francis H
Top HIV Med; 2003; 11(1):20-4. PubMed ID: 12717047
[TBL] [Abstract][Full Text] [Related]
18. Defining rights-based indicators for HIV epidemic transition.
Amon JJ; Eba P; Sprague L; Edwards O; Beyrer C
PLoS Med; 2018 Dec; 15(12):e1002720. PubMed ID: 30576316
[TBL] [Abstract][Full Text] [Related]
19. An interview with Nora Volkow.
Volkow ND
Trends Pharmacol Sci; 2015 Apr; 36(4):187-8. PubMed ID: 25814055
[No Abstract] [Full Text] [Related]
20. National Institute on Drug Abuse International Program: improving opioid use disorder treatment through international research training.
Gust SW; McCormally J
Curr Opin Psychiatry; 2018 Jul; 31(4):287-293. PubMed ID: 29771745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
